Regadenoson Injection, Solution
Product Images NDC 60505-6116

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Regadenoson (NDC 60505-6116). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Regadenoson-injection-carton Label (Regadenoson Injection Carton Label)

Regadenoson Injection 0.4 mg/5 mL (0.08 mg/mL) single-dose prefilled syringe label by Apotex Corp. The intravenous injection solution label includes instructions for aseptic technique, storage information, and a barcode. The label notes the product is sterile, nonpyrogenic, preservative-free, and for diagnostic stress testing use only.*

FDA Label Image

Structure (Structure)

Chemical structure diagram of regadenoson, showing its molecular framework with labeled functional groups and atoms clearly depicted.*

FDA Label Image

Regadenoson-injection-0.4mg/5ml-syringe-label (Syringe Label 02)

Label for Regadenoson Injection 0.4 mg/5 mL (0.08 mg/mL) intravenous solution by Apotex Corp. It indicates use for pharmacologic stress only, provides volume markings for 1 to 5 mL, and includes barcode and manufacturer information for Gland Pharma Limited, India, with manufacturing for Apotex Corp., Weston, Florida.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.